EverGlade Insights Blog
GLIDE_ISO_ARPA-H-SOL-24-111_Final_29_OCT_2024 Program Overview An estimated 10 million Americans are impacted by primary lymphatic diseases, and lymphatic dysfunction contributes to the pathophysiology of many widespread chronic illnesses. Despite the importance of the lymphatic system in disease,...
EverGlade Consulting, is pleased to announce the appointment of Nathan Clark as Director, effective November 2024. Mr. Clark brings an extensive background in government contracting and federal funding management, making him a valuable addition to...
MTEC-FY-2025-Multi-Topic-Pre-Announcement Overview of Solicitation The Medical Technology Enterprise Consortium (MTEC) has released an exciting pre-announcement for its 2025 Multi-Topic Request for Proposals (RPP). This RPP calls for innovative medical prototypes addressing a range of focus...
MCDC 25-01 Innovative Drug Development Pipeline Methods for Rapid Medical Countermeasure (MCM) Development This solicitation from the Medical CBRN Defense Consortium (MCDC), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and...
ARPA-H_DECIDE-ET_Solicitation_DRAFT Overview of Exploration Topic Although Academic Medical Centers (AMCs) have developed many advanced therapies for rare and fatal diseases, access to AMCs remains limited due to outdated production methods and inadequate quality validation. To...
CATALYST_ISO_(DRAFT) Overview of CATALYST Solicitation Current in vivo animal model testing methods often fail to predict human drug safety accurately, leading to inefficiencies and high costs. The Health Science Futures (HSF) Office of the Advanced...